The original headline is too long and uses a colon. I need to rewrite it to be punchy, under 12 words, preserve key facts.

Short summary

Senator Cassidy's 340B reform draft would shift drug pricing from upfront discounts to manufacturer rebates, cap contract pharmacies at five locations, and tighten off-campus facility eligibility. Health systems must model cash-flow impacts (higher upfront costs, 30-90 day rebate delays) and prepare comments by August 28, 2026. This is the most significant 340B overhaul in 15 years.

• •Rebate model shift: health systems pay upfront, wait 30-90 days for reimbursement, creating cash-flow strain
• •Contract pharmacy cap: maximum 5 pharmacies per hospital, restricting patient reach and revenue
• •New eligibility rules for off-campus facilities with 11 distinct requirements, tightening program scope

Generated with AI, which can make mistakes.